Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma

Jeffrey J. Pu, MD PhD, W. Christopher Ehmann, MD, Jason Liao, PhD, Christine Capper, BSN, Michelle Levy, MD, David F. Claxton, MD, Witold B. Rybka, MD, Raymond J. Hohl, MD PhD, Elliot M. Epner, MD PhD

Blood (2016) 128 (22): 1792.

https://doi.org/10.1182/blood.V128.22.1792.1792

Published: 2016

Journal Articles

Dissecting The Effects Of Isoprenoid Pathway Inhibition On Hemostasis and Thrombosis: Differential Effects Of Atorvastatin and Digeranyl Bisphosphonate In Hypercholesterolemic Mice

Neha Bhasin, MD, Jeff Stevens, PhD, Masaru Niki, MD, PhD, Huaxiang Tong, PhD, Craig Kuder, PhD, Raymond J. Hohl, MD, PhD, Steven R Lentz, MD, PhD

Blood (2013) 122 (21): 2378.

https://doi.org/10.1182/blood.V122.21.2378.2378

Published: 2013

Journal Articles

Phase 1 Study of Tabalumab, a Human Anti-BAFF Antibody and Bortezomib in Patients with Previously-Treated Multiple Myeloma

Noopur Raje, MD, Edward Anthony Faber, Jr., DO, MS, Paul G. Richardson, MD, Gary J. Schiller, MD, Raymond J. Hohl, MD, PhD, Adam D. Cohen, MD, Andres Forero, MD, Susan P. Carpenter, PhD, Damien Cronier, PhD, Christopher Kaiser, PhD, James E. Wooldridge, MD, Kenneth C. Anderson, MD

Blood (2012) 120 (21): 447.

https://doi.org/10.1182/blood.V120.21.447.447

Published: 2012

Journal Articles

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Blood (2010) 116 (21): 287.

https://doi.org/10.1182/blood.V116.21.287.287

Published: 2010

Journal Articles

Biochemical Basis for Interactions Between Thalidomide and Inhibitors of the Isoprenoid Biosynthetic Pathway in Multiple Myeloma Cells

Sarah A. Holstein, MD, PhD, Huaxiang Tong, PhD, Raymond J. Hohl, MD, PhD

Blood (2008) 112 (11): 2635.

https://doi.org/10.1182/blood.V112.11.2635.2635

Published: 2008

Journal Articles

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant with GM-CSF Support for Multiple Myeloma.

Annette J. Schlueter, MD, PhD, Judith K. Glasgow, BS, Werner Wilke, MD, PhD, Jacquie R. Marietta, MS, Raymond J. Hohl, MD, PhD, Thomas H. Carter, MD, PhD, Roger D. Gingrich, MD, PhD, Margarida D. Magalhaes-Silverman, MD

Blood (2007) 110 (11): 951.

https://doi.org/10.1182/blood.V110.11.951.951

Published: 2007

Journal Articles

Efficacy and Safety of Denileukin Diftitox (Ontak®) in the Treatment of Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status.

Francine Foss, MD, Madeleine Duvic, MD, Larisa Geskin, MD, Joseph Anderson, MD, Pierluigi Porcu, MD, Raymond J. Hohl, MD,PhD, Maureen Cooper, MD, Jasmine M. Zain, MD, John Zic, MD, Patrica Hibberd, MD,PhD, Mark Acosta, PharmD

Blood (2006) 108 (11): 2712.

https://doi.org/10.1182/blood.V108.11.2712.2712

Published: 2006

Journal Articles

Pilot Study of Lovastatin in Patients with Myelodysplastic Syndrome (MDS) Receiving Arsenic Trioxide (Trisenox®) Therapy.

Ann Stroh, DO, Thomas H. Carter, PhD-MD, Raymond J. Hohl, MD-PhD, Pamela Zehr, Justine M. Ritchie, PhD

Blood (2005) 106 (11): 4928.

https://doi.org/10.1182/blood.V106.11.4928.4928

Published: 2005

Journal Articles

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant for Multiple Myeloma.

Annette J. Schlueter, MD, PhD, Judith K. Glasgow, BS, Werner W. Wilke, MD, PhD, Jacquie R. Marietta, BS, Raymond J. Hohl, MD, PhD, Thomas H. Carter, MD, PhD, Roger D. Gingrich, MD, PhD, Margarida D. Magalhaes-Silverman, MD

Blood (2005) 106 (11): 5212.

https://doi.org/10.1182/blood.V106.11.5212.5212

Published: 2005

Journal Articles

Bisphosphonates Influence Isoprenylation of Small Gtpases in Human Myeloma Cells.

Kelly M. Swanson, DO, Andrew J. Wiemer, MS, Raymond J. Hohl, MD, PhD

Blood (2004) 104 (11): 3401.

https://doi.org/10.1182/blood.V104.11.3401.3401

Published: 2004

NARROW

The Results of a Phase I Study using Velcade (Bortezomib), Cladribine, and Rituximab (VCR) in treating Mantle Cell Lymphoma

Dissecting The Effects Of Isoprenoid Pathway Inhibition On Hemostasis and Thrombosis: Differential Effects Of Atorvastatin and Digeranyl Bisphosphonate In Hypercholesterolemic Mice

Phase 1 Study of Tabalumab, a Human Anti-BAFF Antibody and Bortezomib in Patients with Previously-Treated Multiple Myeloma

A Phase II Study of the Farnesyltransferase Inhibitor Tipifarnib Demonstrates Anti-Tumor Activity In Patients with Relapsed and Refractory Lymphomas

Biochemical Basis for Interactions Between Thalidomide and Inhibitors of the Isoprenoid Biosynthetic Pathway in Multiple Myeloma Cells

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant with GM-CSF Support for Multiple Myeloma.

Efficacy and Safety of Denileukin Diftitox (Ontak®) in the Treatment of Cutaneous T-Cell Lymphoma (CTCL) According to CD25 Status.

Pilot Study of Lovastatin in Patients with Myelodysplastic Syndrome (MDS) Receiving Arsenic Trioxide (Trisenox®) Therapy.

Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant for Multiple Myeloma.

Bisphosphonates Influence Isoprenylation of Small Gtpases in Human Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only